Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist
|
|
- Cynthia Manning
- 6 years ago
- Views:
Transcription
1 Curriculum vitae PERSONAL INFORMATION Gyorgyi Fodor WORK EXPERIENCE September 2011 Present Pharmacovigilance assessor National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Benefit/risk assessment, periodic safety update reports' (PSURs/PRBERs) assessment as lead Member State assessor in the frame of the European Single Assessment (PSUSA) procedures. Signal detection, management. Risk management plans (RMPs) assessment pre- and postmarketing Responsible for assessing and approving Risk Minimisation Measures (RMMs) such as Educational materials prepared by marketing authorisation holders (MAH) and quality control of the PV assessment within the NCA. Review of safety journals, clinical trials, epidemiological studies, and related literature. Quality control of the causality assessment and reporting of ICSRs via the EudraVigilance system to the European Medicines Agency (EMA) Quality control of the ICSR reports sent by MAHs in Hungary. Hungarian delegate and active contributor to the work of the Pharmacovigilance WorkSharing Procedures Working Party (CmDh). Postgraduate educator/lecturer: pharmacovigilance post-graduate curriculum in collaboration with the Semmelweis Medical University of Budapest. Active contributor, author and lecturer in the SCOPE project Work Package 7 Quality management systems in Pharmacovigilance in special topic of Stakeholder feedback and customer satisfaction; active contributor to the work of the WP4 ADR reporting topic as well ( ) - lectures available at the EMA EU Network Training Centre May 2009 June 2011 Acting Chief Pharmacist - Supervising and superintendent pharmacist HSE - St Brendan s Hospital Dublin - Pharmacy Department (Ireland) Responsible for overall professional policy and clinical management of pharmacy practice and administration of sale and supply of drugs, control of pharmacy. Dispensing drugs and controlled drugs to wards of two hospitals, St. Brendan s and St. Ita s psychiatric hospitals, to hostels (patient residential homes) and to out-patients clinics (530 patients in total). Develop and expand ward clinical pharmacy service. Ensuring effective, economical stock control at pharmacy and ward level, record keeping complying with legislation practice guidelines and Health Services Executives standards. Developing and maintaining up-to-date policies governing the pharmacy; ensuring safe working practices are adhered to and quality control of services maintained. Managing staff within the department, collaborate with nursing, medical staff at ward and management level. Ensuring that highest professional, clinical standards are maintained at all times complying with the Pharmacy Act, 2007; ensuring that best practice and Evidence-based guidelines are followed. Drug chart screening and assessment; intervene clinically when deemed to be necessary. Developing and extending the pharmacy service (premises, staff, services) across three individual hospitals psychiatric hospitals and care of elderly patients. Active member of Drugs and Therapeutics Committee and Medication Management work groups developing and updating prescription chart, prescribing guidelines, medication management policies. February 2006 May 2009 Senior hospital Pharmacist HSE - St Brendan s Hospital Dublin - Pharmacy Department (Ireland) 17/10/17 European Union, Page 1 / 7
2 Supplying drugs to the wards of St. Brendan's and St. Ita's Hospital complying with best practice guidelines and legislation. Dispensing Clozaril to outpatients and inpatients, ensuring protocols are followed. Provision of advice to other health care professionals as required for the appropriate and economical use of drugs. Screening kardexes, making interventions to ensure patient safety and safe prescribing. Consulting with other healthcare professionals about medication management. Training new staff; supervision of assigned technicians and pharmacist. Procurement of drugs, ensuring the most optimal stock level. Printing and filing daily audit reports and other requested reports. Dispensing Controlled drugs, and maintaining records. April 2003 February 2006 Senior hospital pharmacist Uzsoki Street General Hospital, Budapest (Hungary) Dispensing drugs to the inpatient wards and outpatients in retail pharmacy settings. Pricing, ordering, invoicing and stock control. Ensuring that the pharmacy operates within the agreed hospital budget. Ensuring the wards operate within the allocated medical expences. Providing reports on medication usage. Dispensing and maintaining record of MDA drugs. Drug compounding (aseptic compounding as well). Provision of information about medicines for patients and healthcare professionals. Control of supply of high-technology oncology drugs. Supervision and training of technicians and assigned staff. Developing and piloting unit dose drug delivery systems. Controlling and managing on-going clinical trials. January 2001 March 2003 CNS Product Manager (psychiatry and neurology) Janssen-Cilag, division of Johnson & Johnson Ltd (Hungary) Increasing the market share and sales of a 7 year old product (psychiatry), launch of new indications and life cycle management. Launching to the market a new antiepileptic product. Organising symposia on national and international conferences. Yearly budget planning and allocating. Presenting lectures and articles release (on International Product Manager s meetings). Building and maintaining professional relationships with specialist lecturers. Producing evidence-based professional promotional materials Training and motivating the sales representatives. Preparing and presenting short- and mid-term Business Plan to the Board and ensuring its execution. Forecasting sales and required production. Being a member of the European Commercial Team, active involvement of implementation and creation of international strategies International Product Manager for antibiotics Chemical Works of Gedeon Richter Ltd (Hungary) Launching new products into the Hungarian and Central-European markets. 17/10/17 European Union, Page 2 / 7
3 Product life-cycle management. Preparation of marketing and business plans; short and midterm planning, forecasting. Leasing with licence partners. Planning short- mid- and long-term competitive product strategies, presenting business plans. Developing promotional campaign, promotional materials. Managing allocated budget. Organising symposia on national and international congresses. Training and motivating medical representatives; preparing presentations and holding lectures. Building and maintaining good relationship with specialist lecturers. Increasing the sales of the product with evidence based promotional materials and other business strategies International market analyst and licensing in executive Chemical Works of Gedeon Richter Ltd. - Strategic marketing department (Hungary) Preparing market research studies covering 10 countries worldwide based on medical and market trends (using IMS-International Medical Statistics and other data). Preparing proposals for future research and development of new products and active ingredients. Identify potential products for licensing-in. Analysing market potential of new products before the launching it. Dealing with the settlement of licence negotiations and agreements. Participating on business talks and delivering business correspondences with national and international partners Basic Grade Hospital Pharmacist Uzsoki Street General Hospital, Budapest (Hungary) Dispensing drugs to the wards. Dispensing and maintaining record of MDA drugs. Drug compounding including aseptic compounding. Provision of medicine information for patients and healthcare professionals. Supervising and training technicians and assigned staff member. EDUCATION AND TRAINING October 2017 October 2017 EVDAS 'train-the-trainer' training on new functionalities (ISO / ICH E2B(R3) European Medicines Agency (EU NTC) (United Kingdom) September 2017 September 2017 EudraVigilance User training ISO / ICH E2B(R3) European Medicines Agency (EMA) (United Kingdom) November 2016 November 2016 PRAC pharmacovigilance assessor training European Medicines Agency (United Kingdom) October 2016 October 2016 Active contributor, author and lecturer SCOPE Work Package 7 Quality Management Systems in Pharmacovigilance and WP5 Signal Management - training course (Hungary) Quality Management in Pharmacovigilance, Signal Management 17/10/17 European Union, Page 3 / 7
4 October 2016 October 2016 Active contributor and participant SCOPE Work Package 4 ADR Reporting training course (United Kingdom) The main objective of the workshop was to learn from the SCOPE research conducted on how to develop ADR reporting systems. This included topics on raising awareness levels, collaboration with patient organisations, reporting tools, additional monitoring, medication errors, IT systems, quality of reports, duplicate detection and some topics from quality management systems from Work Package 7 of SCOPE. September 2016 September 2016 Participation SCOPE Work Package 8 Lifecycle Pharmacovigilance - training course (Portugal) SCOPE is developing recommendations, guidance and training for regulators to support the EU pharmacovigilance network Work Package 8 aims to explore existing standards for pharmacovigilance assessments and a good practices useful to ensure that National Competent Authorities (NCAs) are able to support the Pharmacovigilance Risk Assessment Committee (PRAC) with high-quality assessment and advice on: risk management plans; post authorisation studies, periodic safety update reports and referral procedures. December 2015 December 2015 delegate EMA Signal detection workshop (United Kingdom) November 2015 November 2015 delegate PRAC assessor training (United Kingdom) October 2014 October 2014 Pharmacovigilance assessor training EMA London (United Kingdom) pharmacovigilance (signal detection, PSUR/PSUSA, RMP, PASS...) October 2014 October 2014 Public administration Specialist (higher) examination National University of Public Service Faculty of Public Administration Budapest (Hungary) public administration September 2011 July 2013 Professional English and Hungarian Translator and Interpreter in Health Sciences Medical University of Szeged (Hungary) English/Hungarian medical translations English/Hungarian interpreter March 2013 March 2013 Licensure for ICSR reporting to the EudraVigilance database European Medicines Agency (United Kingdom) EudraVigilance-electronic reporting of ICSRs - EMA training course November 2012 November 2012 MedDRA user MedDRA MSSO (United Kingdom) Coding with MedDRA and MedDRA Safety Data Analysis and SMQs training course 17/10/17 European Union, Page 4 / 7
5 March 2012 March 2012 Public Administration (Hungary) Public Administration basic level state exam February 2012 February 2012 EVDAS user European Medicines Agency (United Kingdom) EV Data Analysis System (EVDAS) Training for National Competent Authorities EMA November 2010 November 2010 Superintendent pharmacist Pharmaceutical Society of Ireland, Irish Centre for Continuing Pharmaceutical Education ICCPE (Ireland) PSI/ICCPE training course for Superintendent Pharmacists November 2010 November 2010 clinical skills HPAI (Hospital Pharmacist Association) (Ireland) Clinical Skills Course Part-II, HPAI Clinical pharmacy training course (2 days) November 2009 November 2009 clinical skills HPAI (Hospital Pharmacist Association) (Ireland) Clinical Skills Course Part-III, HPAI (Hospital Pharmacist Association) Clinical pharmacy training course (2 days) October 2009 October 2009 manager Health Services Executive (HSE) (Ireland) People Management, The legal framework HSE training course September 2008 October 2009 Master of Sciences in Clinical Pharmacy University College Cork and Centre for Advanced Clinical Therapeutics, St. James s Hospital, Dublin (Ireland) Clinical pharmacy, hospital pharmacy, pharmacology, pharmacotherapy, biostatistics, critical appraisal PSI Tutor Pharmacist course Pharmaceutical Society of Ireland (Ireland) Tutor pharmacist in Ireland Specialist Pharmacist in Clinical Pharmacy National Examination Board of Pharmacy (Hungary) October 2002 October 2002 sales management Con Action (United Kingdom) Sales management international training course August 2002 August 2002 lecturer Con Action (United Kingdom) Lecture technique training 17/10/17 European Union, Page 5 / 7
6 May 2001 May 2001 negotiations (Hungary) Negotiation Skills training February 2001 February 2001 marketing master class JS Training (United Kingdom) Practical Training Expertise: Marketing Master Class training Specialist Pharmacist in Clinical Pharmacology National Examination Board of Pharmacy (Hungary) September 1998 September 1998 product management (United Kingdom) Complete Healthcare Training, Practical and Effective Product Management July 1998 July 1998 forcasting (United Kingdom) Complete Healthcare Training, Forecasting Training course June 1997 June 1997 marketing strategies MarkStrat Pharm (United Kingdom) Dynamic Marketing Strategies training September 1994 July 1996 Qualified economist for foreign trade Business College of Foreign Trade, Budapest (Hungary) Economist, marketing specialist May 1995 May 1995 health economic (United Kingdom) Complete Healthcare and Health Economic Training course September 1988 July 1994 Master of Pharmacy degree Semmelweis Medical University, Faculty of Pharmacy (Hungary) Pharmacist ADDITIONAL INFORMATION Expertise -pharmacovigilance (assessment of PSUR/PSUSA, RMP, PASS, ICSR reporting, quality control, educatioinal materials, signal detection) -clinical pharmacy -hospital pharmacy -medication safety at hospital level -medication errors 17/10/17 European Union, Page 6 / 7
7 -CNS -Antiinfectives -pharmacy management, pharma industry - management and marketing Publications Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action Work Package 7 Quality Management Systems: Stakeholder Feedback and Customer Satisfaction (2016) lecture, guidance document and interactive PDF teaching tool published at Projects SCOPE Project Work Package4 and Work Package active participant and author: MSc in Clinical Pharmacy Thesis research: Detailed audit of inpatient prescription writing at St. Brendan's Psychiatric Hospital Dublin, 2009 Clinical Pharmacy Diploma Thesis: The role of the clinical pharmacist in the care of patients with chronic renal failure Budapest, 2005 Pharmacology Diploma Thesis: Pharmacokinetics and pharmacodynamics of the penicillin antibiotics Budapest, 1999 Economist Diploma Thesis: Strategic marketing product management of a drug company. Budapest, 1996 Pharmacy Diploma Thesis: Application of recombinant gene technology in the production of drugs and vaccines. Budapest, 1994 Memberships Registered licensed pharmacist - Pharmaceutical Society of Ireland since registration cancelled in 2013 Registered licensed pharmacist - Hungarian Chamber of Pharmacists since ongoing Hospital Pharmacists Association of Ireland - HPAI United Kingdom Psychiatric Pharmacy Group - UKPPG Irish Psychiatric Pharmacist Group IPPG European Society for Clinical Pharmacy - ESCP Other Relevant Information 17/10/17 European Union, Page 7 / 7
EV Reporting process for users: Creating and sending ICSRs using EVWEB part II
EV Reporting process for users: Creating and sending ICSRs using EVWEB part II Training Module EV-M3e An agency of the European Union Content Summary Introduction Nullifications and Amendments Creating
More informationSafeguarding public health. The New PV Legislation. Perspective from a Member State
Safeguarding public health The New PV Legislation Perspective from a Member State Mick Foy Reinforcing patient safety in Europe, Zagreb June 2011 Content Background The new EU PV Package ADR Definition
More informationGood Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA
Good Pharmacovigilance Practice Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA Content ADR Reporting Definition & Increased scope Transition arrangements
More informationElectronic submission of information on medicinal products in accordance to Article 57(2) requirements: Maintenance submission
Electronic submission of information on medicinal products in accordance to Article 57(2) requirements: Maintenance submission SME workshop: Focus on quality for medicines containing chemical entities
More informationThe New EU PV Legislation: View from the European Commission
The New EU PV Legislation: View from the European Commission International seminar 26 May 2011 Lenita LINDSTRÖM Senior Policy Officer Pharmaceuticals Unit/DG SANCO Rationale for the revision Calls for
More informationImplementation of the new pharmacovigilance legislation: Overall update and activities in 2013
Implementation of the new pharmacovigilance legislation: Overall update and activities in 2013 Workshop for micro, small and medium-sized enterprises (SMEs) European Medicines Agency (EMA), London 26 April
More informationCorporate Induction: Part 2
Corporate Induction: Part 2 Identification of preventable Adverse Drug Reactions from a regulatory perspective March 1 st 2013, EMA Workshop on Medication Errors Presented by Almath Spooner, Pharmacovigilance
More informationSafeguarding public health. The New PV Legislation its Impact on PV & MI
Safeguarding public health The New PV Legislation its Impact on PV & MI Sarah Vaughan - MHRA PIPA 2013 Manager s Meeting 13 th February 2013 Content Scope of change Key areas - ADR reporting - DDPS to
More informationMedDRA User Group. Paris, April 16, 2015 Victoria Newbould, European Medicines Agency. An agency of the European Union
MedDRA User Group Paris, April 16, 2015 Victoria Newbould, European Medicines Agency An agency of the European Union HMA meeting 28 November 2013 HMA agreed with the deliverables to be completed over the
More informationPOSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE
POSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE 2018/2020 University of Dublin, Trinity College Index Introduction... 1 Aims... 1 Intended Participants... 1 Course Structure... 2 Course Content and
More informationInformation Brochure Professional Certificate in Pharmacovigilance
Information Brochure Professional Certificate in Pharmacovigilance Catalyst Clinical Services Pvt. Ltd. Unit No. 11, CSC-12, Block D1, Sector-16, Rohini, Delhi - 110089 (India) M: +91 9818356273 Email:
More informationThe Pharmaceutical Risk Assessment Committee (PRAC) of the EMA
The Pharmaceutical Risk Assessment Committee (PRAC) of the EMA Albert van der Zeijden (PRAC member) Expert representing patients perspective Eurordis Summerschool Friday June 5, 2015 Content The history
More informationMix of civil law and common law. Official law database Ministry for justice, culture and local government of Malta
Malta European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.
More informationDraft EU Guidance on Medication Errors
Draft EU Guidance on Medication Errors Revision after PSQCWG and PRAC consultation PSQCWG meeting Brussels, 11 February 2015 Presented by Dr. Thomas Goedecke Senior Scientific Officer, Regulatory Affairs
More information...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS
...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS 1 Table of Contents Pg 3 Pg 4 Pg 5 About Ivowen Limited Meet the team Pharmaceutical Regulatory Affairs Services: Human & Veterinary Pg 5 Pg 5 National Procedures
More informationSCOPE Work Package 4 ADR Collection. Medication Errors
Medication Errors Contents Acknowledgments 3 1. Introduction 4 1.3 Definitions and abbreviations 5 2. Medication errors 7 2.1 Coding of medication errors 7 2.2 Exemption from liability for HCPs when reporting
More informationOverview of e-portfolio Learning Activities for Part III Community Pharmacy Placements
Overview of e-portfolio Learning Activities for Part III Community Pharmacy Placements Placement Module 2 & 3 The following sections must be completed for Placement. Pre-placement Preparation My Glossary
More informationProfessional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.
Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7
More informationDrug Safety Research Unit. DSRU Education & Training
Drug Safety Research Unit DSRU Education & Training Courses and Symposia 2017 Experts in Pharmacovigilance Education www.dsru.org Welcome Welcome to the latest Drug Safety Research Unit (DSRU) Course and
More informationThe European network evaluation of the PHAR QA framework of competences for...
The European network evaluation of the PHAR QA framework of competences for... The PHAR QA ( Quality assurance in European pharmacy education and training ) funded by the European Commission, will produce
More informationAdopted by Pharmacovigilance Risk Assessment Committee 20 February Adopted by Pharmacovigilance Inspectors Working Group 21 March 2014
21 March 2014 EMA/INS/PhV/192231/2014 Union procedure on the management of pharmacovigilance inspection findings which may impact the robustness of the benefit-risk profile of the concerned medicinal Adopted
More informationPharmacist (Palliative Care) December 2014 Page 1
Job Profile Job Title: Department: Main Location: Hospice Palliative Care Pharmacist 7 NHS (8SRC) Less than full time(0.8) Full time equivalent around 36,300 Head of Clinical Services 1. Main Purpose of
More informationDANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE
DANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE BACKGROUND AND AIMS This project focuses on the core competences Danish pharmaconomists receive through their education and their work areas.
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationPHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT)
AC ANNEX 1 & 2 PHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT) Pharmaceutical Society of Singapore Alumni
More informationGuidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business
Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business to facilitate compliance with Regulation 12 of the Regulation of Retail Pharmacy Businesses
More informationBASG / Austrian Medicines and Medical Devices Agency Institute Assessment & Analytics Traisengasse 5, A-1200 Vienna
This guidance document is intended to provide applicants with detailed information on the operational procedure of National Scientific Advice (NASA) by the Austrian Federal Office for Safety in Health
More informationEuropean network of paediatric research (EnprEMA)
20 December 2010 EMA/770017/2010 Human Medicines Development and Evaluation Recognition criteria for self assessment The European Medicines Agency is tasked with developing a European paediatric network
More informationWHO Pharmacovigilance Indicators. Dr. Nitin Gaikwad Co-coordinator, ADR Monitoring Center, PvPI Additional Professor, Pharmacology AIIMS Raipur
WHO Pharmacovigilance Indicators Dr. Nitin Gaikwad Co-coordinator, ADR Monitoring Center, PvPI Additional Professor, Pharmacology AIIMS Raipur Scope of presentation Sensitization of Coordinators, Co-coordinators,
More informationNCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets.
NCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets. Version Date Amendment Approved By 1 11/01/2017 Version 1 NCCP following consultation
More informationPatient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force
5 May 2017 EMA/180341/2017 Inspections, Human Medicines, Pharmacovigilance and Committees Division Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force EMA Initiative 1.
More informationMeasures of impact of pharmacovigilance processes (3.3)
Measures of impact of pharmacovigilance processes (3.3) Session 4 - Reports from breakout sessions: gaps and observations Workshop: Measuring the Impact of Pharmacovigilance Activities London, 5-6 December
More informationResponsible medication processes ( pharmaceutical care ) and good pharmaceutical practices for improved patients quality of life and batter healthcare
Responsible medication processes ( pharmaceutical care ) and good pharmaceutical practices for improved patients quality of life and batter healthcare INTRODUCTION This summary provides - an evaluation
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationImplementing Changes in Pharmacovigilance Regulations. Presented by Dr Ennis H Lee, Senior Partner, TranScrip 14 June 2016
s Presented by Dr Ennis H Lee, Senior Partner, TranScrip 14 June 2016 Monitor for changes in regulations Regulatory Authority websites Pharmaceutical industry bodies Pharmaceutical press Use global subsidiaries
More informationCapturing the value of SCOPE to the EU Flagship Event London, 23 November 2016
Capturing the value of SCOPE to the EU Flagship Event London, 23 November 2016 Helen Lee European Commission, Health and Food Safety Directorate General Outline of the presentation Characterisitics of
More informationLicensed Pharmacy Technicians Scope of Practice
Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationMore information can be found on the Austrian country profile of the Pharmine Website
AAHP - Austrian Association of Hospital Pharmacists Postgraduate specialisation in hospital pharmacy is available in Austria. Although, not mandatory to practice the completion of the Weiterbildung zum
More informationThere must be a clearly worded statement outlining the goals of the residency program and the educational objectives of the residents.
Specific Standards of Accreditation for Residency Programs in Clinical Pharmacology and Toxicology 2013 VERSION 2.0 INTRODUCTION A university wishing to have an accredited program in Clinical Pharmacology
More informationStrengthening Collaborations for Operating Pharmacovigilance in Europe (SCOPE) Joint Action
www.scopejointaction.eu Strengthening Collaborations for Operating Pharmacovigilance in Europe (SCOPE) Joint Action The SCOPE Joint Action has received funding from the European Union Contents 1. Overall
More informationWork plan for GCP Inspectors Working Group for 2018
22 March 2018 EMA/87812 /2018 Committees and Inspections Chairperson: Ana Rodriguez The activities outlined in the work plan for 2018 have been agreed in view of preparation for the Agency s relocation
More informationMedDRA Coding and Medication Error Topics. Patrick Revelle (MSSO)
MedDRA Coding and Medication Error Topics Patrick Revelle (MSSO) Topics for Presentation MSSO's MedDRA maintenance role MedDRA's history with medication errors Developmental efforts FAERS and ICSRs MedDRA
More informationUse of disease registries for benefitrisk evaluation of medicines: A regulatory perspective. DIA Europe April Basel, Switzerland
Use of disease registries for benefitrisk evaluation of medicines: A regulatory perspective DIA Europe 2018-17-19 April Basel, Switzerland Presented by Xavier Kurz Head of Service Surveillance and Epidemiology
More information1. Inpatient Pharmacy Services Log Book
1 PRP log Books 1. Inpatient Pharmacy Services Log Book A. KKM log book requirements: (Duration of attachment: 8 weeks) Items Descriptions Measurement Remarks Management of inpatient pharmacy/satellite
More informationJOB DESCRIPTION. 1 year fixed term. Division A Pharmacy. University Hospitals Birmingham. Advanced Clinical Pharmacist Trials.
JOB DESCRIPTION JOB TITLE: Pharmacy Technician Haematology Clinical Trials PAY BAND: Agenda for change - Band 5 TERMS AND CONDITIONS DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PROFESSIONALLY RESPONSIBLE
More informationJOB DESCRIPTION. The hospital has been consistently growing over the past few years, almost doubling since 2008.
JOB DESCRIPTION JOB TITLE: Clinical Pharmacist CLINICAL UNIT: Pharmacy BASE: The Portland Hospital for Women and Children MANAGED BY: Pharmacy Manager ACCOUNTABLE TO: Pharmacy Manager HOSPITAL PROFILE
More informationguide AUGUST 2017 for Pharmacist Salary Banding
guide AUGUST 2017 for Pharmacist Salary Banding in New Zealand Pharmacist Salary Banding introduction The Pharmaceutical Society of New Zealand has produced this guide to provide a national remuneration
More informationNORTHERN IRELAND MEDICINES OPTIMISATION SCALING UP INNOVATION ACROSS EUROPE
NORTHERN IRELAND MEDICINES OPTIMISATION SCALING UP INNOVATION ACROSS EUROPE Northern Ireland - Who are we? Challenge faced medicines optimisation Strategic approach to upscaling good practice Upscaling
More informationINVOLVING PATIENTS IN PHARMACOVIGILANCE EPF TOOLKIT. Susanna Palkonen, EPF Board Member
INVOLVING PATIENTS IN PHARMACOVIGILANCE EPF TOOLKIT Susanna Palkonen, EPF Board Member EPF About us Independent, non-governmental umbrella organisation set up in 2003 VISION: High-quality, patientcentred,
More informationOverview of comments received on draft 'Good practice guide on recording, coding, reporting and assessment of medication errors' (EMA/762563/2014)
23 October 2015 EMA/190895/2015 Pharmacovigilance Risk Assessment Committee Overview of comments received on draft 'Good practice guide on recording, coding, reporting and assessment of medication errors'
More informationSOP Title: Reporting Adverse Events and New Safety Information
Page 1 of 14 General Control of medication use requires collecting field data about adverse events (AEs) resulting from medication therapy. Regulation 7(B)(2) of Pharmacists Regulations (Medical Products)
More informationSCOPE Work Package 4 ADR Collection. Handling Telephone Calls from the Public
ADR Collection Handling Telephone Calls from the Public Contents Acknowledgments 3 1. Introduction 4 1.1 Purpose of the document 4 1.2 Background 4 1.3 Regulatory requirements 6 1.4 Definitions and abbreviations
More informationGuideline on good pharmacovigilance practices (GVP)
9 October 2017 2017 EMA/118465/2012 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module XV Safety communication (Rev 1) Date for coming into effect of first version 24 January 2013 Draft
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationPG Certificate / PG Diploma / MSc in Clinical Pharmacy
PG Certificate / PG Diploma / MSc in Clinical Pharmacy 2008/09 Programme Course manager: Brian McCaw (b.mccaw@qub.ac.uk) Distance Learning Centre The School of Pharmacy Queen's University Belfast PG Certificate
More informationDelivery time frame for the EU portal and EU database
17 December 2015 EMA/760345/2015 Endorsed Draft time frame presented to European Medicines Agency Management Board 01 October 2015 Draft timeframe presented to IT Directors and Member States during the
More informationGuidance for registered pharmacies preparing unlicensed medicines
Guidance for registered pharmacies preparing unlicensed medicines May 2014 The text of this document (but not the logo and branding) may be reproduced free of charge in any format or medium, as long as
More informationRe: 42 CFR Part 485; Medicare Program; Conditions of Participation (CoPs) for Community Mental Health Centers
August 12, 2011 Centers for Medicare & Medicaid Services Department of Health and Human Services P.O. Box 8013 Baltimore, MD 21244-8013 Re: 42 CFR Part 485; Medicare Program; Conditions of Participation
More informationEuropean Patients Academy (EUPATI) Update
European Patients Academy (EUPATI) Update EMA meeting with patient/consumer organisations 11 Dec 2013 Maria Mavris EURORDIS // EUPATI WP4 Co-Lead For patient-centric medicines R&D and to contribute to
More informationHospital Pharmacists making the difference in medication use
The European Association of Hospital Pharmacists EAHP the association for all hospital pharmacists in Europe Hospital Pharmacists making the difference in medication use www.eahp.eu 1 Introduction to EAHP
More informationWHO Programme for International Drug Monitoring, Pharmacovigilance Centres & Patient Safety
WHO Programme for International Drug Monitoring, Pharmacovigilance Centres & Patient Safety Birth of WHO Drug Monitoring Programme Thalidomide Phocomelia 2 16th World Health Assembly 1963 Assembly Resolution
More informationSFHPHARM11 - SQA Unit Code FA2X 04 Prepare extemporaneous medicines for individual use
Prepare extemporaneous medicines for individual use Overview This standard covers your role in preparing extemporaneous medicines for individual use. This involves accurately calculating the quantities
More informationFoundation in Paediatric Pharmaceutical Care 5th International Masterclass
Leading the field in paediatric courses for pharmacists Foundation in Paediatric Pharmaceutical Care 5th International Masterclass 15-17 October 2015 Evelina London Children s Hospital Guy s and St Thomas
More informationPharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA
Pharmacovigilance: The patient s Perspective Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA Scope of presentation Why is Pharmacovigilance important for patients?
More informationLegislations and Policies in Jordan/ Related to Health and Pharmaceuticals April 19, 2018
Legislations and Policies in Jordan/ Related to Health and Pharmaceuticals April 19, 2018 Dr. Rania Bader, HRH2030 Health Workforce Competency Lead HRH2030 The Human Resources for Health (HRH2030) is a
More informationCONSULTANT PHARMACIST INSPECTION LAW REVIEW
CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted
More informationMedicines Management Policy
Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationLatin America: An Evolving Regulatory Environment September 15, Mapi 2015, All Rights Reserved
Latin America: An Evolving Regulatory Environment September 15, 2015 Mapi 2015, All Rights Reserved Upcoming Live Webinar Event: Key Information Featured Webinar Hosts Silvia Bendiner Director of Strategic
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL REPORTING ADVERSE DRUG REACTIONS IN SOUTH AFRICA IMPORTANT NOTE This guideline applies only to the reporting of SAEs during clinical trials. An update of the guideline for this
More informationREVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY
REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version. Overarching and Governance Statements 1. The overarching
More informationFoundation in Paediatric Pharmaceutical Care 5th International Masterclass
Leading the field in paediatric courses for pharmacists Foundation in Paediatric Pharmaceutical Care 5th International Masterclass 15-17 October 2015 Guy s and St Thomas NHS Foundation Trust In collaboration
More informationJob Description. Basic Grade Pharmacy Technician
Job Description Job Title Basic Grade Pharmacy Technician Job Grade Basic Grade Location of Post Pharmacy Department, Temple Street Children s University Hospital Competition Reference HR382 Notes to Applicants
More informationGood Pharmacy Practice in Spanish Community Pharmacy
GENERAL PHARMACEUTICAL COUNCIL OF SPAIN Good Pharmacy Practice in Spanish Community Pharmacy 01 Dispensing Service for Medicines and Medical Devices This document has been developed by the Good Pharmacy
More informationCurrent status on Adverse Event Reporting in Japan
Current status on Adverse Event Reporting in Japan Iku Mitta Safety Reports Management Division, Office of Safety I PMDA 1 Abbreviation ADR: Adverse Drug Reaction DB: Database EPPV:Early Post-Marketing
More informationImplementation of STOPP/START criteria in different settings
Implementation of criteria in different settings Professor Cristín Ryan School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin. October 2017 PhD Thesis (2006-2009), University College Cork
More informationSchool of Pharmacy. Dual Degree. Courses Pharmacy Practice Courses. Programs Doctor of Philosophy (PhD) Doctor of Pharmacy (PharmD)
School of Pharmacy 1 School of Pharmacy Website (http://www.northeastern.edu/bouve/pharmacy) John R. Reynolds, PharmD Professor and Dean Pharmaceutical Sciences 140 The Fenway 617.373.3406 617.373.8886
More informationDisease State Management Clinics: A Pharmacist Perspective
Disease State Management Clinics: A Pharmacist Perspective Eva Berrios Colon, Pharm.D, MPH, BCPS Associate Professor, Touro College of Pharmacy Email: evb9001@nyp.org 5/12/11 The Brooklyn Hospital Center
More informationP1 Fall SCCP 602/COP 601: Foundations of Pathophysiology and Pharmacology I This is the first course in a 2-semester sequence providing important
P1 Fall SCCP 602/COP 601: Foundations of Pathophysiology and Pharmacology I This is the first course in a 2-semester sequence providing important physiologic, pathophysiologic and pharmacologic principles
More informationPatient Registries Initiative Background, Achievements, Next steps
Patient Registries Initiative Background, Achievements, Next steps 21 November 2017 ENCePP Plenary meeting Presented by Xavier Kurz, Surveillance & Epidemiology Service, European Medicines Agency An agency
More informationUncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES
Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company
More informationWhat does governance look like in homecare?
What does governance look like in homecare? Dr David Cousins PhD FRPharmS Head of Pa)ent Safety, Healthcare at Home Ltd This Satellite is sponsored by Healthcare at Home Ltd Definitions Clinical governance
More information7 th European Forum for Qualified Person for Pharmacovigilance (QPPV)
7 th European Forum for Qualified Person for Pharmacovigilance (QPPV) Event #13104 17-18 April 2013 Hotel Holiday Inn Bloomsbury, London, UK 16 April 2013 - Pre-Conference Workshop Programme Co-Chairs
More informationCare Home support and medicines optimisation: Community Pharmacy National Enhanced Service
Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem
More informationCourse Descriptions COLLEGE OF PHARMACY
Course Descriptions COLLEGE OF PHARM 3001 INTRODUCTION TO One hour lecture. Required in the first professional semester, orientates entering students for the College of Pharmacy and initiates concepts
More informationGuidance notes for patient safety and pharmacovigilance in patient support programmes
Guidance notes for patient safety and pharmacovigilance in patient support programmes Authors: The ABPI Pharmacovigilance Expert Network Version: 2.14 Date: March 2018 Acknowledgements: We thank the many
More informationPharmacovigilance & Managed Care Pharmacy. Issues for Medication Safety in Korea
Pharmacovigilance and Managed Care Pharmacy Issues for Medication Safety in Korea Hyun Taek Shin, Pharm.D. Professor, College of Pharmacy Sookmyung University & President, Korean Academy of Managed Care
More informationStephen C. Joseph, M.D., M.P.H.
JUL 26 1995 MEMORANDUM FOR: ASSISTANT SECRETARY OF THE ARMY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE NAVY (MANPOWER & RESERVE AFFAIRS) ASSISTANT SECRETARY OF THE AIR FORCE (MANPOWER, RESERVE
More informationPOLICY ON NURSE PRESCRIBING IN OLCHC EDITION 6
POLICY ON NURSE PRESCRIBING IN OLCHC EDITION 6 Version Number 6 Date of Issue 23 rd December 2015 Reference Number Review Interval Approved By Name: Rachel Kenna Title: Director of Nursing Title: Drugs
More informationGlobal Medical Safety Post-Doctoral Global Medical Safety (GMS) Fellowship
Global Medical Safety Post-Doctoral Global Medical Safety (GMS) Fellowship 2017-2018 Janssen R&D US A Message from the Head of Global Medical Organization At Janssen Pharmaceutical Companies of Johnson
More informationCourse Descriptions for PharmD Classes of 2021 and Beyond updated November 2017
Course Descriptions for PharmD Classes of 2021 and Beyond updated November 2017 PHRD 510 - Pharmacy Seminar I Credit: 0.0 hours PHRD 511 Biomedical Foundations Credit: 4.0 hours This course is designed
More informationReaccreditation of an Education and Training Programme to prepare Pharmacist Independent Prescribers, Queen s University Belfast
Reaccreditation of an Education and Training Programme to prepare Pharmacist Independent Prescribers, Queen s University Belfast Report of a reaccreditation event, 23 November, 2015 Introduction The General
More informationInternational Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services
International Pharmaceutical Federation Fédération internationale pharmaceutique PO Box 84200, 2508 AE The Hague, The Netherlands Standards for Quality of Pharmacy Services Standards are an important part
More informationJOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.
JOB DESCRIPTION JOB TITLE: Clinical Pharmacy Technician PAY BAND: 5 DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PHARMACY/A5 University Hospitals Birmingham Pharmacy Support Manager PROFESSIONALLY RESPONSIBLE
More informationPSUR and PSUR repository. Legal basis. PSUR/PBRER General comments
PSUR and PSUR repository Mag. Dr. Irmgard Resch Dep. Assessment Pharmacovigilance AGES-Gespräche Vienna, 22.9.2015 www.basg.gv.at Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Legal
More informationGuidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities. July 2011
Guidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities July 2011 Introduction: This guidance sets out strengthened governance arrangements required
More informationSCHOOL OF NURSING DEVELOP YOUR NURSING CAREER WITH THE UNIVERSITY OF BIRMINGHAM
SCHOOL OF NURSING DEVELOP YOUR NURSING CAREER WITH THE UNIVERSITY OF BIRMINGHAM 2 English Language and Applied Linguistics Welcome to Nursing at the University of Birmingham We continuously develop our
More informationPharmacy Department PRE-REGISTRATION TRAINEE PHARMACIST INFORMATION PACK
Pharmacy Department PRE-REGISTRATION TRAINEE PHARMACIST INFORMATION PACK 2 INDEX 1. Chelsea and Westminster Hospital 3 2. The Pharmacy 3 3. Services 3 4. Education and Training 5 5. Miscellaneous 5.1 Social
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationICH STEERING COMMITTEE October 24-29, 2009 St. Louis, MO, USA SUMMARY
ICH STEERING COMMITTEE October 24-29, 2009 St. Louis, MO, USA SUMMARY 1. Opening Discussions The ICH Steering Committee (SC) meeting was chaired by the FDA. The meeting commenced with the provision of
More information